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The rise of prescription of psychotropic drugs is a major
healthcare problem namely in Psychiatry. The reason of
the rise is not clear and many questions remain unan-
s w e r e d .F u r t h e r m o r e ,w eh a v em o r ep a t i e n t s ,m o r e
drugs, more resistant and demanding patients and more
polypharmacy. Inappropriate prescribing and lack of
rational is not uncommon and prescribing education is
also a main concern. Although, the use of guidelines for
treatment could make clinical work easier they differ in
their objectives and contents. We will discuss the doc-
tor’s capacity to make more diagnosis, the problematic
of out of label prescriptions and the potential of abuse
of some medication and the implications in the rise of
prescription. The continuous update and training in
clinical psychopharmacology and joint decision-making
process between clinicians will allow a rational approach
to treatment.
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